Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image

Mark Bensink, PhD, MSc, MEd

Articles by Mark Bensink, PhD, MSc, MEd

The Long-term Social Value of Granulocyte Colony-Stimulating Factors

ByAlison Sexton Ward, PhD,Mina Kabiri, PhD,Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD,Alison R. Silverstein, MPH,Emma van Eijndhoven, MS, MA,Charles Bowers, MD,Mark Bensink, PhD, MSc, MEd,Dana Goldman, PhD

Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.

Latest Updated Articles